Oral Anticoagulation Compared to Left Atrial Appendage Closure Following Catheter Ablation: Results From the OPTION Trial

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Cleveland Clinic Heart & Vascular Institute, Cleveland Clinic Heart, and Vascular Institute 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

2M ago 19:47

MP3•에피소드 홈

A Cleveland Clinic-led trial found that a minimally-invasive procedure – left atrial appendage closure (LAAC) – resulted in significantly less bleeding in patients undergoing a catheter ablation to treat atrial fibrillation, compared to oral anticoagulation, while preserving low rates of stroke, blood clots and death. The OPTION Trial was presented at the American Heart Association’s Scientific Sessions 2024. Walid Saliba, MD speaks with Oussama Wazni, MD, Section Head of Cardiac Electrophysiology and Pacing at Cleveland Clinic and Primary Investigator of the OPTION Trial, about the results of the trial and implications for practice.
Learn more about the Atrial Fibrillation Stroke Prevention Center
https://my.clevelandclinic.org/departments/heart/depts/atrial-fibrillation-stroke-prevention-center
Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET), toll-free 800.223.2273, ext. 49162

302 에피소드